Norplant and Excessive or unwanted hair in women - a phase IV clinical study of FDA data
Excessive or unwanted hair in women is found among people who take Norplant, especially for people who are female, 20-29 old.
The phase IV clinical study analyzes which people take Norplant and have Excessive or unwanted hair in women. It is created by eHealthMe based on reports of 6,416 people who have side effects when taking Norplant from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
6,416 people reported to have side effects when taking Norplant.
Among them, 221 people (3.44%) have Excessive or unwanted hair in women.
What is Norplant?
Norplant has active ingredients of levonorgestrel. It is often used in birth control. eHealthMe is studying from 6,430 Norplant users for its effectiveness, alternative drugs and more.
What is Excessive or unwanted hair in women?
Excessive or unwanted hair in women is found to be associated with 1,142 drugs and 810 conditions by eHealthMe.
Number of Norplant and Excessive or unwanted hair in women reports submitted per year:
Gender of people who have Excessive or unwanted hair in women when taking Norplant*:
Age of people who have Excessive or unwanted hair in women when taking Norplant *:
Common drugs people take besides Norplant *:
Common side effects people have besides Excessive or unwanted hair in women *:
* Approximation only. Some reports may have incomplete information.
Do you take Norplant and have Excessive or unwanted hair in women?Check whether Excessive or unwanted hair in women is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Excessive or unwanted hair in women and when was it recovered:
Expand to all the drugs that have ingredients of levonorgestrel:
Alternative drugs to, pros and cons of Norplant:
- Norplant (6,430 reports)
Common Norplant side effects:
- Weight increased: 1,616 reports
- Hair loss: 871 reports
- Pain: 828 reports
- Depression: 810 reports
- Heavy or prolong menstrual bleeding: 805 reports
- Amenorrhea (absence of a menstrual period in a woman of reproductive age): 727 reports
- Abdominal pain: 653 reports
Browse all side effects of Norplant:a b c d e f g h i j k l m n o p q r s t u v w x y z
Excessive or unwanted hair in women treatments and more:
- Excessive or unwanted hair in women (4,646 reports)
COVID vaccines that are related to Excessive or unwanted hair in women:
- Excessive or unwanted hair in women in Moderna COVID Vaccine
- Excessive or unwanted hair in women in Pfizer BioNTech Covid Vaccine
- Excessive or unwanted hair in women in Johnson and Johnson Covid Vaccine
Common drugs associated with Excessive or unwanted hair in women:
- Mirena: 510 reports
- Minoxidil: 342 reports
- Norplant: 221 reports
- Omeprazole: 163 reports
- Prednisone: 130 reports
- Cyclosporine: 117 reports
All the drugs that are associated with Excessive or unwanted hair in women:
- Excessive or unwanted hair in women (1,142 drugs)
Common conditions associated with Excessive or unwanted hair in women:
- Birth control: 454 reports
- Hair loss: 195 reports
- Gastroesophageal reflux disease: 139 reports
- High blood pressure: 114 reports
All the conditions that are associated with Excessive or unwanted hair in women:
- Excessive or unwanted hair in women (810 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on levonorgestrel (the active ingredients of Norplant) and Norplant (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cetirizine Hydrochloride vs. Ranitidine - a second ago
- Hyzaar vs. Olmesartan Medoxomil; Hydrochlorothiazide - 3 seconds ago
- Intal vs. Qnasl - 6 seconds ago
- Restoril vs. Oleptro - 8 seconds ago
- Vasotec vs. Irbesartan - 12 seconds ago
- Olmesartan Medoxomil; Hydrochlorothiazide vs. Midodrine Hydrochloride - 12 seconds ago
- Cesamet vs. Lorazepam - 16 seconds ago
- Cataflam vs. Effexor - 17 seconds ago
- Coreg vs. Micardis Hct - 24 seconds ago
- Omega 3 vs. Omega-3 Oil - 25 seconds ago